Clinical Trial Detail

NCT ID NCT02178956
Title A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications

gastric adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

Napabucasin

Paclitaxel

Age Groups: adult

No variant requirements are available.